Primary biliary cirrhosis (PBC) is a chronic progressive cholestatic granulomatous, and
destructive inflammatory lesion of small intralobular and septal bile ducts, which is likely to …

Liver enzymes are commonly used in the evaluation of patients with a range of diseases.
Classically they are used to give information on whether a patient's primary disorder is …

The development of liver fibrosis markers in primary biliary cirrhosis (PBC) is needed to
facilitate the assessment of its progression and the effectiveness of new therapies. Here, we …

BACKGROUND Noninvasive methods have been developed to detect fibrosis in many liver
diseases due to the limits of liver biopsy. However, previous studies have focused primarily …

Background Fibrosis stage predicts prognosis in patients with chronic liver disease
independent of aetiology, although its precise role in risk stratification in patients with …

OBJECTIVES: Noninvasive markers of liver fibrosis in patients with primary biliary cirrhosis
(PBC) are needed for predicting disease progression. As theWisteria floribundaagglutinin …

Background Obeticholic acid (OCA) was recently approved as the only on‐label alternative
for patients with primary biliary cholangitis (PBC) with intolerance or suboptimal response to …

Scope Disturbances in one‐carbon metabolism contribute to nonalcoholic fatty liver disease
(NAFLD) which encompasses steatosis, steatohepatitis, fibrosis, and cirrhosis. The goal is to …

Аннотация Цель обзора. Прогноз и тактика ведения пациентов с хроническими
заболеваниями печени любой этиологии во многом определяются степенью развития и …

BACKGROUND AND STUDY AIMS: Fibroscan and APRI are promising noninvasive
alternatives to liver biopsy for detecting hepatic fibrosis. However, their overall test …